Skip to content
Saturday, February 16, 2019
ISI Impact Factor: 0.862 (2017)
  • NeuroPharmac 2016
  • NeuroPharmac 2017
  • NeuroPharmac 2018

NeuroPharmac Journal

ISSN: 2456-3927

  • Editorial board
  • Instructions to Author
  • submission
  • current issue
  • Archive
  • Indexing
  • Copyright
  • Dr. Aslam Lab
    • Publications
    • Books
    • Patent
  • Articles in Press
  • Contact Us
  • Alzheimer’s Disease: Pharmacotherapy of noncognitive symptoms
    Alzheimer’s Disease: Pharmacotherapy of noncognitive symptoms

    2018, Volume 3, Issue 1 (Jan-April) [Download Full PDF]

  • Comparative study between open & closed dressing in healing of burn wound
    Comparative study between open & closed dressing in healing of burn wound

    2018, Volume 3, Issue 1 (Jan-April) [Download Full PDF]

  • Alzheimer’s Disease: Pharmacotherapy of subjective cognitive decline
    Alzheimer’s Disease: Pharmacotherapy of subjective cognitive decline

    2018, Volume 3, Issue 2 (May-August) [Download Full PDF]

  • Gold Standard of Symptomatic treatment in Parkinson disease: Carbidopa/Levodopa
    Gold Standard of Symptomatic treatment in Parkinson disease: Carbidopa/Levodopa

    2018, Volume 3, Issue 3 (Sept-Dec) [Download Full PDF]

  • Possible management of non-motor symptoms of Parkinson’s Disease
    Possible management of non-motor symptoms of Parkinson’s Disease

    2018, Volume 3, Issue 3 (Sept-Dec) [Download Full PDF]

Quick Links

  • Editorial board
  • Instructions to Author
  • submission
  • current issue
  • Archive
  • Indexing
  • Copyright
  • Dr. Aslam Lab
    • Publications
    • Books
    • Patent
  • Articles in Press
  • Contact Us

Archive

  • NeuroPharmac 2016
  • NeuroPharmac 2017
  • NeuroPharmac 2018

Our Indexing

© 2016 All rights reserved | NeuroPharmac Journal

Proudly powered by WordPress | Theme: SuperMag by Acme Themes